The antibody inhibits cleavage of C5 into the anaphylatoxin C5a and C5b, the initial component of TCC assembly, thereby blocking the terminal pathway of the complement (Figure 1) [26]. Here, C5 is linked to tarsal-carpal coalition syndrome.